Antidepressant black box warning
The black box warning on antidepressants is a warning printed in a box at the top of the US prescribing information, where the FDA calls it a boxed warning. It says antidepressants increased the risk of suicidal thoughts and behaviors in children, teenagers and young adults in short-term studies, and asks that everyone taking one be watched closely for worsening. The increase was seen in people under 25, at about 4 in 100 compared with 2 in 100 on a dummy pill, and not in older adults. The risk is highest in the first months and after dose changes.
Also called: Boxed warning, Black box warning, FDA suicidality warning.
Written by Alena Kozlova, PhD, from published studies and prescribing information.
Definition medically reviewed by Dr. Jason Tan, Consultant Psychiatrist, on November 11, 2026, this definition only. Next review: November 11, 2027.
What does the antidepressant black box warning say?
Besides the risk itself, the box says what it wants done about it: anyone started on an antidepressant is monitored closely for clinical worsening and for suicidal thoughts and behavior, most closely in the first few months and at every change of dose, up or down. It also asks that families and caregivers be told what to look for, so someone close to you can notice a change you miss.
The figures behind it come from pooled trials that every antidepressant label carries. In children and adolescents the pool was 24 short-term trials of 9 antidepressants in over 4,400 patients. In adults it was 295 short-term trials, median length 2 months, of 11 antidepressants in over 77,000 patients.
What do the risk numbers on the label mean?
They are the difference from placebo for every 1,000 people treated in those short-term trials, counted as cases of suicidality, which on the label means suicidal thoughts and behavior rather than deaths. The Lexapro and Wellbutrin XL labels give the same set: 14 more cases under 18, 5 more at 18 to 24, 1 fewer at 25 to 64, and 6 fewer at 65 and older.
No suicides occurred in any of the pediatric trials. There were suicides in the adult trials, and the labels say the number was not enough to reach any conclusion about a drug effect on suicide. The trials were short, so these figures describe the first weeks and months of treatment, and they show a pattern by age rather than your own odds.
Which antidepressants have a black box warning?
All of them. Every antidepressant approved in the US carries the same boxed warning and the same pooled figures, whatever class it belongs to. It stands on the Lexapro (escitalopram) and Prozac (fluoxetine) labels and on the Wellbutrin XL (bupropion) label, which is a different class of medication, in slightly different words but to the same effect. So the box in your leaflet does not mark your medication as riskier than the next one.
Does the warning mean you should not take an antidepressant?
No. What it asks for is watching. In the pooled trials the increase showed in people under 25. From 25 upward the figures came out slightly below placebo, and the Wellbutrin XL box says the trials did not show an increase in risk at 65 and older, which is not the same as saying the medication protects you: a difference of 1 case in 1,000 cannot carry that.
The Lexapro label puts the other side of the scale next to the same numbers. There is substantial evidence from placebo-controlled maintenance trials in adults with depression that antidepressants delay the recurrence of depression, and depression itself is a risk factor for suicidal thoughts and behaviors. Whether to start, stay on or change a medication is a decision to make with your prescriber.
What should you watch for?
The labels name anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia, which is being unable to sit still with your body driving you to move, hypomania and mania, together with any unusual change in behavior and depression that is persistently worse. They ask families and caregivers to watch for these and report them to a health care provider immediately, above all when the symptoms are severe or start suddenly.
If you're having thoughts of harming yourself, contact emergency services or a crisis line straight away. In the US, call or text 988. In the UK, call Samaritans on 116 123. Elsewhere, call your local emergency number or find a crisis line near you.
What to do
In the first weeks and after any dose change, note changes in mood, sleep and restlessness, and ask someone close to you to tell you if they notice changes. Tell your prescriber about anything new rather than waiting for the next appointment.
Find a crisis line near you
How withClaro helps
- Track mood daily through the first weeks
- Share a record with your prescriber
Get the withClaro app on the App Store
Related terms
Sources
- U.S. Food and Drug Administration. Lexapro (escitalopram) tablets and oral solution: prescribing information. FDA / DailyMed, 2026.
- U.S. Food and Drug Administration. Prozac (fluoxetine): prescribing information. FDA / DailyMed, 2026.
- U.S. Food and Drug Administration. Wellbutrin XL (bupropion extended-release tablets): prescribing information. FDA / DailyMed, 2026.
All glossary terms